Legal & General Group PLC Neogenomics Inc Transaction History

Legal & General Group PLC

  • $368 Billion
  • Q4 2024

A detailed history of Legal & General Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 356,814 shares of NEO stock, worth $3.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
356,814
Previous 367,374 2.87%
Holding current value
$3.96 Million
Previous $5.42 Million 8.53%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$13.0 - $18.43 $137,280 - $194,620
-10,560 Reduced 2.87%
356,814 $5.88 Million
Q3 2024

Nov 14, 2024
BUY
$13.4 - $17.73 $16,361 - $21,648
1,221 Added 0.33%
367,374 $5.42 Million
Q2 2024

Aug 14, 2024
BUY
$13.01 - $15.77 $123,165 - $149,294
9,467 Added 2.65%
366,153 $5.08 Million
Q1 2024

May 14, 2024
BUY
$14.06 - $16.79 $1,040 - $1,242
74 Added 0.02%
356,686 $5.61 Million
Q4 2023

Feb 15, 2024
BUY
$11.67 - $20.73 $14,377 - $25,539
1,232 Added 0.35%
356,612 $5.77 Million
Q3 2023

Nov 14, 2023
SELL
$12.15 - $17.85 $85,244 - $125,235
-7,016 Reduced 1.94%
355,380 $4.37 Million
Q2 2023

Aug 14, 2023
SELL
$14.1 - $19.83 $68,173 - $95,878
-4,835 Reduced 1.32%
362,396 $5.82 Million
Q1 2023

May 15, 2023
BUY
$9.09 - $19.45 $33,096 - $70,817
3,641 Added 1.0%
367,231 $6.39 Million
Q4 2022

Feb 14, 2023
BUY
$6.45 - $12.07 $58,759 - $109,957
9,110 Added 2.57%
363,590 $3.36 Million
Q3 2022

Nov 14, 2022
SELL
$7.86 - $12.91 $8,355 - $13,723
-1,063 Reduced 0.3%
354,480 $3.05 Million
Q2 2022

Aug 22, 2022
SELL
$7.06 - $13.97 $637,694 - $1.26 Million
-90,325 Reduced 20.26%
355,543 $2.9 Million
Q1 2022

May 16, 2022
BUY
$12.15 - $35.28 $188,154 - $546,346
15,486 Added 3.6%
445,868 $5.42 Million
Q4 2021

Feb 14, 2022
BUY
$30.49 - $48.49 $1.14 Million - $1.81 Million
37,282 Added 9.48%
430,382 $14.7 Million
Q3 2021

Nov 15, 2021
BUY
$41.66 - $52.52 $1.14 Million - $1.44 Million
27,381 Added 7.49%
393,100 $19 Million
Q2 2021

Aug 12, 2021
SELL
$36.62 - $51.69 $2.72 Million - $3.84 Million
-74,269 Reduced 16.88%
365,719 $16.5 Million
Q1 2021

May 17, 2021
BUY
$41.56 - $59.88 $2.78 Million - $4 Million
66,839 Added 17.91%
439,988 $21.2 Million
Q4 2020

Feb 12, 2021
BUY
$36.08 - $56.47 $496,569 - $777,196
13,763 Added 3.83%
373,149 $20.1 Million
Q3 2020

Nov 13, 2020
BUY
$33.26 - $40.48 $156,820 - $190,863
4,715 Added 1.33%
359,386 $13.3 Million
Q2 2020

Aug 14, 2020
BUY
$24.21 - $31.02 $820,331 - $1.05 Million
33,884 Added 10.56%
354,671 $11 Million
Q1 2020

May 14, 2020
BUY
$20.5 - $34.53 $568,465 - $957,516
27,730 Added 9.46%
320,787 $8.87 Million
Q4 2019

Feb 13, 2020
BUY
$18.96 - $29.84 $383,048 - $602,857
20,203 Added 7.4%
293,057 $8.57 Million
Q3 2019

Nov 13, 2019
BUY
$19.12 - $26.24 $623,732 - $856,001
32,622 Added 13.58%
272,854 $5.22 Million
Q2 2019

Aug 14, 2019
BUY
$19.57 - $24.1 $354,784 - $436,908
18,129 Added 8.16%
240,232 $5.27 Million
Q1 2019

May 15, 2019
BUY
$12.14 - $20.46 $2.55 Million - $4.3 Million
210,139 Added 1756.43%
222,103 $4.55 Million
Q4 2018

Feb 15, 2019
BUY
$11.24 - $18.5 $15,792 - $25,992
1,405 Added 13.31%
11,964 $151,000
Q3 2018

Nov 20, 2018
BUY
$12.5 - $15.38 $12,037 - $14,810
963 Added 10.04%
10,559 $162,000
Q2 2018

Aug 10, 2018
SELL
$7.99 - $14.05 $3,643 - $6,406
-456 Reduced 4.54%
9,596 $125,000
Q1 2018

May 17, 2018
SELL
$7.23 - $8.76 $26,447 - $32,044
-3,658 Reduced 26.68%
10,052 $82,000
Q4 2017

Feb 13, 2018
BUY
$8.02 - $11.18 $109,954 - $153,277
13,710
13,710 $122,000

Others Institutions Holding NEO

# of Institutions
282
Shares Held
124M
Call Options Held
751K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.4B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email